ARTICLE | Company News
A.P. Pharma, Paul Capital Partners deal
January 18, 2010 8:00 AM UTC
A.P. Pharma received the final $2.5 million milestone payment from Paul Capital's Paul Royalty Fund under a 2005 deal in which Paul Capital purchased royalty rights to A.P. Pharma's acne drug Retin-A...